Details for New Drug Application (NDA): 013993
✉ Email this page to a colleague
NDA 013993 describes CHROMITOPE SODIUM, which is a drug marketed by Bracco and is included in one NDA. Additional details are available on the CHROMITOPE SODIUM profile page.
The generic ingredient in CHROMITOPE SODIUM is sodium chromate cr-51. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium chromate cr-51 profile page.
The generic ingredient in CHROMITOPE SODIUM is sodium chromate cr-51. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium chromate cr-51 profile page.
Summary for 013993
| Tradename: | CHROMITOPE SODIUM |
| Applicant: | Bracco |
| Ingredient: | sodium chromate cr-51 |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200uCi/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2mCi/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
